Alpha-1 adrenergic receptor and 5-alpha reductase enzyme — Drug Target

All drugs that target Alpha-1 adrenergic receptor and 5-alpha reductase enzyme — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Alpha-blocker and 5-alpha reductase inhibitor combination

Phase 3 pipeline (1)

• Maintenance of alpha-blocker and 5-ARI · Gangnam Severance Hospital · Alpha-blocker and 5-alpha reductase inhibitor combination · Urology
  This combination therapy maintains symptom relief in benign prostatic hyperplasia by combining alpha-blocker-mediated smooth muscle relaxation with 5-alpha reductase inhibitor-mediated reduction of prostate volume.